Catheterization for Congenital Heart Disease Adjustment for Risk Method II
Authors:
- Brian P. QuinnBQBrian P. Quinn
- Sarah G. KotinSKSarah G. Kotin
- Kimberlee GauvreauKGKimberlee Gauvreau
- Mary J. YehMYMary J. Yeh
- John LozierJLJohn Lozier
- Oliver M. BarryOBOliver M. Barry
- Shabana ShahanavazSSShabana Shahanavaz
- Sarosh P. BatlivalaSBSarosh P. Batlivala
- Arash SalavitabarASArash Salavitabar
- Susan FoersterSFSusan Foerster
- 1 March 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 17 (3) , e012834
Abstract
BACKGROUND: Current metrics used to adjust for case mix complexity in congenital cardiac catheterization are becoming outdated due to the introduction of novel procedures, innovative technologies, and expanding patient subgroups. This study aims to develop a risk adjustment methodology introducing a novel, clinically meaningful adverse event outcome and incorporating a modern understanding of risk. METHODS: Data from diagnostic only and interventional cases with defined case types were collected for patients ≤18 years of age and ≥2.5 kg at all Congenital Cardiac Catheterization Project on Outcomes participating centers. The derivation data set consisted of cases performed from 2014 to 2017, and the validation data set consisted of cases performed from 2019 to 2020. Severity level 3 adverse events were stratified into 3 tiers by clinical impact (3a/b/c); the study outcome was clinically meaningful adverse events, severity level ≥3b (3bc/4/5). RESULTS: The derivation data set contained 15 224 cases, and the validation data set included 9462 cases. Clinically meaningful adverse event rates were 4.5% and 4.2% in the derivation and validation cohorts, respectively. The final risk adjustment model included age P value, 0.83; Brier score, 0.042). CONCLUSIONS: CHARM II (Congenital Heart Disease Adjustment for Risk Method II) risk adjustment methodology allows for equitable comparison of clinically meaningful adverse events among institutions and operators with varying patient populations and case mix complexity performing pediatric cardiac catheterization.Keywords
This publication has 15 references indexed in Scilit:
- Changes in Practice/Outcomes of Pediatric/Congenital Catheterization in Response to the First Wave of COVIDJACC: Advances, 2022
- ICU Admission Tool for Congenital Heart Catheterization (iCATCH): A Predictive Model for High Level Post-Catheterization Care and Patient ManagementPediatric Critical Care Medicine, 2022
- Nine Lessons Learned From the COVID-19 Pandemic for Improving Hospital Care and Health Care DeliveryJAMA Internal Medicine, 2021
- Validation and refinement of the catheterization RISk score for pediatrics (CRISP score): An analysis from the congenital cardiac interventional study consortiumCatheterization and Cardiovascular Interventions, 2018
- Is Endomyocardial Biopsy a Safe and Useful Procedure in Children with Suspected Cardiomyopathy?Pediatric Cardiology, 2016
- Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: Results of a multicenter experienceThe Journal of Heart and Lung Transplantation, 2012
- Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM)JACC: Cardiovascular Interventions, 2011
- Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 2 – Nomenclature of complications associated with interventional cardiology)Cardiology in the Young, 2011
- Report from The International Society for Nomenclature of Paediatric and Congenital Heart Disease: cardiovascular catheterisation for congenital and paediatric cardiac disease (Part 1 – Procedural nomenclature)Cardiology in the Young, 2011
- Adverse event rates in congenital cardiac catheterization — A multi‐center experienceCatheterization and Cardiovascular Interventions, 2009